{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_015921.5:c.1331C>A",
          "cDNA Change": {
            "transcript": "NM_015921.5",
            "ref": "C",
            "alt": "A",
            "position": "1331"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "437"
          },
          "Description in input context": "c.1331C>A (p.W437X)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease, familiar form",
    "MONDO": "MONDO:0006748"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial Respiratory Function Analysis",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived fibroblasts and normal control fibroblasts",
        "Description": "The study used fibroblasts derived from the patient with PINK1 mutation and age-matched healthy controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015921.5:c.1331C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Mitochondrial respiratory function was significantly impaired in patient fibroblasts compared to controls, indicating a loss of PINK1 function."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "The number of biological replicates is not explicitly mentioned."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "The number of technical replicates is not explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No explicit mention of positive controls in the methodology."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit mention of negative controls in the methodology."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Custom",
        "Source": "Based on standard mitochondrial function assays, a respiratory control ratio above 1.5 is typically considered normal.",
        "Description": "Assumed based on common thresholds in mitochondrial studies."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Custom",
        "Source": "Based on standard mitochondrial function assays, a respiratory control ratio below 1.0 may indicate dysfunction.",
        "Description": "Assumed based on common thresholds in mitochondrial studies."
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Mitochondrial respiratory function analysis is a well-established method for studying Parkinson disease, particularly in the context of PINK1 mutations."
      }
    },
    {
      "Assay Method": "Reactive Oxygen Species (ROS) Measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived fibroblasts and normal control fibroblasts",
        "Description": "The study measured ROS levels in fibroblasts to assess mitochondrial dysfunction."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015921.5:c.1331C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "ROS levels were elevated in patient fibroblasts, indicating oxidative stress due to impaired mitochondrial function."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "The number of biological replicates is not explicitly mentioned."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "The number of technical replicates is not explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No explicit mention of positive controls in the methodology."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit mention of negative controls in the methodology."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Custom",
        "Source": "Based on standard ROS measurement assays, levels below 1.0 fluorescence unit are typically considered normal.",
        "Description": "Assumed based on common thresholds in oxidative stress studies."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Custom",
        "Source": "Based on standard ROS measurement assays, levels above 2.0 fluorescence units may indicate significant oxidative stress.",
        "Description": "Assumed based on common thresholds in oxidative stress studies."
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "ROS measurement is a widely accepted method for assessing mitochondrial dysfunction in the context of Parkinson disease."
      }
    }
  ]
}